Abstract: A data processing system implements receiving a first input in a spreadsheet in a spreadsheet application, detecting an indication that the first input includes first executable program code, analyzing the first executable program code to identify first references to one or more first elements of the spreadsheet in the first executable program code, requesting spreadsheet data associated with the one or more first elements of the spreadsheet from the spreadsheet application, receiving the spreadsheet data from the spreadsheet application; executing the first executable program code using the spreadsheet data referenced in the first executable program code to obtain a first program code result and causing the spreadsheet application to display the first program code result in the spreadsheet application.

Abstract: A shooting rest, components thereof, and associated methods. The shooting rest includes a frame, a forward firearm support connected to the frame, and a rear firearm support connected to the frame. The rear firearm support includes a stop configured to limit rearward movement of the firearm with respect to the frame when the firearm is fired. A liquid tank is supported by the frame and is configured to hold liquid to increase the effective mass of the shooting rest to reduce recoil felt by a shooter when the firearm is fired.

Abstract: A knife comprising a handle and a blade assembly. The blade assembly includes a blade, a tang, and blade assembly connection structure. The handle includes a receiver configured to receive the tang, and includes handle connection structure. The blade assembly connection structure and handle connection structure are arranged to releasably lock the blade assembly in an installed position on the handle with the tang in the tang receiver.

Abstract: An intravascular catheter for peri-vascular and/or peri-urethral tissue ablation includes multiple needles advanced through supported guide tubes which expand around a central axis to engage the interior surface of the wall of the renal artery or other vessel of a human body allowing the injection an ablative fluid for ablating tissue, and/or nerve fibers in the outer layer or deep to the outer layer of the vessel, or in prostatic tissue. The system may also include a means to limit and/or adjust the depth of penetration of the ablative fluid into and beyond the tissue of the vessel wall. The catheter may also include structures which provide radial and/or lateral support to the guide tubes so that the guide tubes expand uniformly and maintain their position against the interior surface of the vessel wall as the sharpened injection needles are advanced to penetrate into the vessel wall.

Abstract: A multi-legged equipment support, components thereof, and associated methods. The equipment support comprises a stand and an equipment holder. The stand includes a hub and multiple legs pivotable with respect to the hub. The legs are pivotable outward from stowed positions to preset operational pivoted positions. The user can select a preset operational pivoted position in which outward pivoting of a leg will stop based on moving an actuator between preset locations.

Abstract: Systems and methods for operating an antenna assembly. The methods comprise: receiving, at the first polarized antenna, a first signal comprising a desired signal emitted from a first signal source located at a first altitude higher than a second altitude of the antenna assembly and an interfering signal emitted from a second signal source located at a third altitude lower than the second altitude; receiving the interfering signal at the second polarized antenna (where the first and second polarized antennas have opposite circular polarizations); generating a second signal by shifting a phase of the interfering signal which was received at the second polarized antenna by an amount to cause the second signal to be out-of-phase with the first signal; and providing an antenna pattern with a null at or below a horizon by destructively combining the second signal with the first signal.

Abstract: Weapon accessory mount assembly, components thereof, and associated methods. A weapon accessory mount assembly mounts on first and second rails having respective first and second slots of different sizes. The assembly includes an accessory mount for attaching to an accessory and a rail mount for attaching to the first and second rails. The assembly also includes a rail slot key having a first key portion to be inserted into the first slot and a second key portion to be inserted into the second slot to inhibit longitudinal movement of the assembly along the respective first and second rails when mounted thereon.

Abstract: The present invention provides pharmaceutical compositions, for storage and administration, comprising an anti-human B7-H3 (“hB7-H3”) antibody (“enoblituzumab”) and buffering agents. The invention provides containers and kits comprising such pharmaceutical compositions. The invention further provides the use of such pharmaceutical compositions, containers, and kits containing enoblituzumab for the treatment of a cancer, and in certain aspects, treatment of a cancer expressing B7-H3.

Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.

Abstract: Described herein are intracameral implants including at least one therapeutic agent for treatment of at least one ocular condition. The implants described herein are not anchored to the ocular tissue, but rather are held in place by currents and gravity present in the anterior chamber of an eye. The implants are preferably polymeric, biodegradable and provide sustained release of at least one therapeutic agent to both the trabecular meshwork and associated ocular tissue and the fluids within the anterior chamber of an eye.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.

Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on at least one of a level of the one or more characteristics of the first fluid or the one or more characteristics of the second fluid.

Abstract: The present invention relates to Tri-Specific Binding Molecules, which are multi-chain polypeptide molecules that possess three Binding Domains and are thus capable of mediating coordinated binding to three epitopes. The Binding Domains may be selected such that the Tri-Specific Binding Molecules are capable of binding to any three different epitopes. Such epitopes may be epitopes of the same antigen or epitopes of two or three different antigens. In a preferred embodiment, one of such epitopes will be capable of binding to CD3, the second of such epitopes will be capable of binding to CD8, and the third of such epitopes will be capable of binding to an epitope of a Disease-Associated Antigen. The invention also provides a novel ROR1-binding antibody, as well as derivatives thereof and uses for such compositions.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.

Abstract: Container including base portion defining compartment. Base portion includes bottom panel defining bottom of compartment, front base panel defining front of compartment and extending upwardly from bottom panel. Base portion further includes back panel extending from bottom panel to define a back of compartment, and first and second side tabs extending between bottom panel, front base panel, and back panel at opposing sides thereof to define opposing sides of compartment. Container further includes lid portion including a top panel and a front lid panel. The top panel includes an opening and an access flap moveable between an opening position and a closed position defining the opening. The access flap includes a back edge, a front edge, opposing side edges, and a first and second front protrusions, respectively. Blanks for forming such a container and methods for disposing a web material are also disclosed.

Abstract: The present disclosure is provides pharmaceutical compositions, for storage and administration, comprising a human PD-1 (“hPD-1”) antibody (“retifanlimab”) and buffering agents. The disclosure further provides containers and kits comprising such pharmaceutical compositions. The disclosure further provides the use of such pharmaceutical compositions, containers, and kits containing retifanlimab in the treatment of a cancer, and in certain aspects treatment of a cancer expressing PD-L1.

Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on at least one of a level of the one or more characteristics of the first fluid or the one or more characteristics of the second fluid.

Abstract: A building management system (BMS) for filtering a fluid within a building is shown. The system includes one or more sensors configured to measure one or more characteristics of a first fluid within an air duct of the BMS and measure one or more characteristics of a second fluid after the second fluid has been filtered. The system further includes a pollutant management system configured to receive data from the one or more sensors and control a filtration process. The filtration process selects a filter of a plurality of filters based on a level of the one or more characteristics of the first fluid and the one or more characteristics of the second fluid.

Abstract: Disclosed are antiseptic compositions for disinfecting tissues, in particular for ocular use. Methods and compositions disclosed herein include sodium chlorite, optionally in combination with a surfactant.